首页|中药及其活性成分靶向lncRNA治疗卵巢癌的研究进展

中药及其活性成分靶向lncRNA治疗卵巢癌的研究进展

扫码查看
lncRNA是一类长度超过200个核苷酸且不具备蛋白质编码作用的RNA。目前发现,lncRNA可通过调控癌细胞增殖迁移及侵袭、细胞凋亡、耐药细胞敏感性及上皮间充质转化等多种过程参与OC生命进程,了解lncRNA对揭示OC发生机制和挖掘肿瘤治疗新靶点至关重要。近年来,中药抗OC因其安全性高、副作用少等优点而备受关注,国内外多项研究均发现其可以靶向多种lncRNA以达到影响癌细胞生物学行为的目的,而多条信号通路的调控被认为在此过程发挥着极为重要的作用,但其相关机制尚未有统一定论。笔者通过检索几个数据库,对中药及其多酚类、黄酮类、皂苷类、生物碱类等多种活性成分调控lncRNA抗OC的相关文献进行总结,发现其均可通过靶向不同的lncRNA进而调控OC生长、细胞凋亡或耐药细胞敏感性等,这不仅为中药在OC治疗中发挥作用的相关机制研究提供了新视角,也为进一步深入研究和临床运用推广提供依据。
Research Progress on Traditional Chinese Medicine and Its Active Ingredients Targeting lncRNA for the Treatment of Ovarian Cancer
Long non-coding RNA(lncRNA)is a class of RNA with a length of more than 200 nucleotides and no protein coding function.Current-ly,lncRNA has been found to participate in the life process of ovarian cancer(OC)by regulating the proliferation,migration and invasion of cancer cells,the apoptosis and sensitivity of drug-resistant cells and epithelial mesenchymal transformation.Understanding the role of lncRNA is of great importance to reveal the tumorigenesis mechanism behind OC and explore new therapeutic targets.In recent years,traditional Chi-nese medicine(TCM)has gained attention in the field of OC treatment due to its high safety and few side effects.A number of domestic and foreign studies have found that TCM can target multiple lncRNA to affect the biological behavior of cancer cells.The regulation of multiple signaling pathways is considered to play an extremely important role in this process,but a unified consensus on the mechanisms has not yet been reached.By reviewing several databases,we have summarized the research on how TCM and its active ingredients,such as polyphenols,flavonoids,saponins,and alkaloids,regulate lncRNA to combat OC.It has been found that all of these ingredients target different lncRNA to regulate OC growth,apoptosis or sensitivity of drug-resistant cells.Our work not only provides a new perspective for studying the mechanisms through which TCM exerts the effects in OC treatment,but also offers a basis for further research and clinical application and promotion.

Traditional Chinese medicineLong non-coding RNAOvarian cancerActive ingredientsResearch progress

解娅娅、沈影、唐茂艳、刘少璇、李佳、刘芳媛、韩凤娟

展开 >

黑龙江中医药大学,哈尔滨 150040

黑龙江中医药大学附属第一医院,哈尔滨 150040

中药 长链非编码RNA 卵巢癌 活性成分 研究进展

2024

中药药理与临床
中国药理学会 四川省中医药科学院

中药药理与临床

北大核心
影响因子:0.996
ISSN:1001-859X
年,卷(期):2024.40(11)